Iridex Corp (IRIX) Cash Flow Statement

Click line-items for a historical chart and %

Net income	-898K
Depreciation and amortization
Loss on liquidation of foreign subsidiary
Stock compensation recognized
Provision for doubtful accounts	66K
Provision for inventory reserves
Accounts receivable	1.29M
Inventories	-1.57M
Prepaid expenses and other current assets
Other long term assets
Accounts payable	249K
Accrued compensation	2K
Accrued expenses and deferred rent	16K
Accrued warranty
Deferred revenue	-6K
Net cash provided by operating activities
Purchases of property and equipment	-792K
Purchase of RetinaLabs
Net cash used in investing activities
Proceeds from stock option exercises	650K
Repurchase of common stock	-59K
Proceeds from borrowings
Repayment of borrowings
Net cash used in financing activities
Effect of foreign exchange rate changes
Net decrease in cash and cash equivalents	-418K
Cash and cash equivalents at beginning of period	10M
Cash and cash equivalents at end of period	9.58M
Contingent consideration - cash
Shares issued at acquisition
Contingent consideration - additional shares

Entities mentioned with IRIX

View All Entities